Clinical Outcomes and Host Immune Response in Vascular Graft and Endograft Infections

Recruiting
18 years or above
All
Phase N/A
300 participants needed
1 Location

Brief description of study.

ACHIEVE is a prospective observational cohort and biobank study of patients with suspected or diagnosed central vascular graft or endograft infection. The study also includes patients undergoing elective central vascular graft or endograft implantation and healthy blood donor controls. Participants undergo longitudinal clinical data collection and biospecimen sampling. The study aims to characterize clinical outcomes, host immune responses, inflammatory biomarkers, pathogen-related factors, and novel microbiological diagnostic methods, including microbial cell-free DNA sequencing, in vascular graft and endograft infections.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Vascular Graft Infection, Vascular Endograft Infection, Aortic Graft Infection
  • Age: 18 years or above
  • Gender: All

Inclusion Criteria:

  • Age 18 years or older.
  • Able and willing to provide informed consent.
  • For the vascular graft or endograft infection group: suspected or diagnosed vascular graft or endograft infection in a central vascular prosthesis as determined by the treating clinicians.
  • For the elective vascular graft or endograft control group: planned central vascular graft or endograft implantation.
  • For the healthy blood donor control group: active blood donor registered at Aarhus University Hospital Blood Bank.
  • For the healthy blood donor control group: no current infection or other active disease.

Exclusion Criteria:

  • For the elective vascular graft or endograft control group: surgery performed as an emergency procedure within 24 hours.
  • For the elective vascular graft or endograft control group: reoperation of a previously implanted vascular graft or endograft.
  • For the elective vascular graft or endograft control group: evidence suggestive of ongoing infection in the area of surgery.
  • Unable to provide informed consent.

Updated on 09 Jul 2026. Study ID: 1-10-72-114-23

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team